References
Alvarez C., Tredwell S., De Vera M. and Hayden M. 2006 The genotype-phenotype correlation of hereditary multiple exostoses. Clin. Genet. 70, 122–130.
Bellaiche Y., The I. and Perrimon N. 1998 Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature 394, 85–88.
Bovee J. V., Cleton-Jansen A. M., Wuyts W., Caethoven G., Taminiau A. H., Bakker E. et al. 1999 EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am. J. Hum. Genet. 65, 689–698.
Francannet C., Cohen-Tanugi A., Le Merrer M., Munnich A., Bonaventure J. and Legeai-Mallet L. 2001 Genotype-phenotype correlation in hereditary multiple exostoses. J. Med. Genet. 38, 430–434.
Gu W., Zhang F. and Lupski J. R. 2008 Mechanisms for human genomic rearrangements. Pathogenetics 1, 4.
Hameetman L., Szuhai K., Yavas A., Knijnenburg J., Van Duin M., Van Dekken H. et al. 2007 The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. J. Natl. Cancer Inst. 99, 396–406.
Hecht J. T., Hogue D., Wang Y., Blanton S. H., Wagner M., Strong L. C. et al. 1997 Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. Am. J. Hum. Genet. 60, 80–86.
Hennekam R. C. 1991 Hereditary multiple exostoses. J. Med. Genet. 28, 262–266.
Jennes I., De Jong D., Mees K., Hogendoorn P. C., Szuhai K. and Wuyts W. 2011 Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families. BMC Med. Genet. 12, 85.
Jennes I., Entius M. M., Van Hul E., Parra A., Sangiorgi L. and Wuyts W. 2008 Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas. J. Mol. Diagn. 10, 85–92.
Jennes I., Pedrini E., Zuntini M., Mordenti M., Balkassmi S., Asteggiano C. G. et al. 2009 Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum. Mutat. 30, 1620–1627.
Legeai-Mallet L., Munnich A., Maroteaux P. and Le Merrer M. 1997 Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin. Genet. 52, 12–16.
McCormick C., Leduc Y., Martindale D., Mattison K., Esford L. E., Dyer A. P. et al. 1998 The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat. Genet. 19, 158–161.
McCormick C., Duncan G., Goutsos K. T. and Tufaro F. 2000 The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc. Natl. Acad. Sci. USA. 97, 668–673.
Park K. J., Shin K. H., Ku J. L., Cho T. J., Lee S. H., Choi I. H. et al. 1999 Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses. J. Hum. Genet. 44, 230–234.
Pedrini E., Jennes I., Tremosini M., Milanesi A., Mordenti M., Parra A. et al. 2011 Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of “protective” and “risk” factors. J. Bone Joint Surg. Am. 93, 2294–2302.
Porter D. E., Lonie L., Fraser M., Dobson-Stone C., Porter J. R., Monaco A. P. et al. 2004 Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J. Bone Joint Surg. Br. 86, 1041–1046.
Sarrion P., Sangorrin A., Urreizti R., Delgado A., Artuch R., Martorell L. et al. 2013 Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas. Sci. Rep. 3, 1346.
Seki H., Kubota T., Ikegawa S., Haga N., Fujioka F., Ohzeki S. et al. 2001 Mutation frequencies of EXT1 and EXT2 in 43 Japanese families with hereditary multiple exostoses. Am. J. Med. Genet. 99, 59–62.
Szuhai K., Jennes I., De Jong D., Bovee J. V., Wiweger M., Wuyts W. et al. 2011 Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum. Mutat. 32, E2036–E2049.
Vink G. R., White S. J., Gabelic S., Hogendoorn P. C., Breuning M. H. and Bakker E. 2005 Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations. Eur. J. Hum. Genet. 13, 470–474.
Vujic M., Bergman A., Romanus B., Wahlstrom J. and Martinsson T. 2004 Hereditary multiple and isolated sporadic exostoses in the same kindred: identification of the causative gene (EXT2) and detection of a new mutation, nt112delAT, that distinguishes the two phenotypes. Int. J. Mol. Med. 13, 47–52.
Wuyts W., Schmale G. A., Chansky H. A. and Raskind W. H. 1993 Hereditary multiple osteochondromas. In Gene reviews (ed. R. A. Pagon, M. P. Adam, H. H. Ardinger, T. D. Bird, C. R. Dolan, C. T. Fong, R. J. H. Smith and K. Stephens). University of Washington, Seattle.
Xu L., Xia J., Jiang H., Zhou J., Li H., Wang D. et al. 1999 Mutation analysis of hereditary multiple exostoses in the Chinese. Hum. Genet. 105, 45–50.
Acknowledgements
We would like to thank the patients and their families.
Author information
Authors and Affiliations
Corresponding author
Additional information
[Tanteles G. A., Nicolaou M., Neocleous V., Shammas C., Loizidou M. A., Alexandrou A., Ellina E., Patsia N., Sismani C., Phylactou L. A. and Christophidou-Anastasiadou V. 2015 Genetic screening of EXT1 and EXT2 in Cypriot families with hereditary multiple osteochondromas. J. Genet. 94, xx–xx]
Rights and permissions
About this article
Cite this article
TANTELES, G.A., NICOLAOU, M., NEOCLEOUS, V. et al. Genetic screening of EXT1 and EXT2 in Cypriot families with hereditary multiple osteochondromas. J Genet 94, 749–754 (2015). https://doi.org/10.1007/s12041-015-0564-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-015-0564-3